ArticleBiomimetics (Basel, Switzerland)2025
Mobile Mental Health Screening in EmotiZen via the Novel Brain-Inspired MCoG-LDPSNet.
Article in Biomimetics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anxiety and depression affect millions worldwide, yet stigma and long wait times often delay access to care. Mobile mental health apps can decrease these barriers by offering on-demand screening and support. Nevertheless, many machine and deep learning methods used in such tools perform poorly under severe class imbalance, yielding biased, poorly calibrated predictions. To address this challenge, this study proposes MCoG-LDPSNet, a brain-inspired model that combines dual, orthogonal encoding pathways with a novel Loss-Driven Parametric Swish (LDPS) activation. LDPS implements a neurobiologically motivated adaptive-gain mechanism via a learnable β parameter driven by calibration and confidence-aware loss signals that amplifies minority-class patterns while preserving overall reliability, enabling robust predictions under severe data imbalance. On a benchmark mental health corpus, MCoG-LDPSNet achieved AUROC = 0.9920 and G-mean = 0.9451, outperforming traditional baselines like GLMs, XGBoost, state-of-the-art deep models (CNN-BiLSTM-ATTN), and transformer-based approaches. After transfer learning to social media text, the MCoG-LDPSNet maintained a near-perfect AUROC of 0.9937. Integrated into the EmotiZen App with enhanced app features, MCoG-LDPSNet was associated with substantial symptom reductions (anxiety 28.2%; depression 42.1%). These findings indicate that MCoG-LDPSNet is an accurate, imbalance-aware solution suitable for scalable mobile screening of individuals for anxiety and depression.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.